Invited Presentations

2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992

2021Back to top

          1. 278. Quantifying Human Exposure to Emerging Contaminants of Concern using Mass Spectrometry
            David C. Muddiman
            Isotope Day, Cambridge Isotope Laboratories, Tewsbury, MA 2021
          2. 277. Scientific Discovery and Impact Through Innovative Mass Spectrometry Measurements: From Plants and Model Organisms to Humans
            David C. Muddiman
            Department of Chemistry, George Washington University, Washington, DC 2021
          3. 276. Scientific Discovery and Impact Through Innovative Mass Spectrometry Measurements: From Plants and Model Organisms to Humans
            David C. Muddiman
            Central Ohio Mass Spectrometry Discussion Group, Columbus, OH  2021
          4. 275. Scientific Discovery and Impact through Innovative Mass Spectrometry Measurements: From Plants and Model Organisms to Humans
            David C. Muddiman
            Department of Chemistry and Biochemistry, Auburn University, Auburn, AL 2021

        2020Back to top

                1. 274. New Directions for IR-MALDESI Mass Spectrometry Imaging: From Cells and Bones to Drift Tube Ion Mobility
                  David C. Muddiman and Erin S. Baker
                  Mass Spectrometry Applications to the Clinical Laboratory, Palm Springs, CA 2020
                2. 273. New Directions for IR-MALDESI Mass Spectrometry Imaging: From Cells, Bones and Neurotransmitters to Drift Tube Ion Mobility
                  David C. Muddiman and Erin S. Baker
                  United States Human Proteome Organization, Seattle, WA 2020
                3. 272. Scientific Discovery and Impact Through Innovative Mass Spectrometry Measurements: From Plants and Model Organisms to Humans
                  David C. Muddiman
                  Thermo Fisher Scientific Global Sales Meeting, San Antonio, TX  2020
                4. 271. Unraveling Chemical and Biological Systems Through the Development and Application of Innovative Mass Spectrometry Platform Technologies
                  David C. Muddiman
                  Department of Marine, Earth and Atmospheric Sciences, NC State University, Raleigh, NC 2020

              2019Back to top

                      1. 270. IR-MALDESI Coupled with Ion Mobility: Early Results
                        David C. Muddiman
                        1st Annual North American Ion Mobility User Meeting, Alumni Center, NC State University, Raleigh, NC 2019
                      2. 269. High Throughput Screening by Adaptation of IR-MALDESI-MS
                        David C. Muddiman
                        Southeastern Regional Meeting of the American Chemical Society, Savannah, GA 2019
                      3. 268. Infrared Matrix-Assited Laser Desorption Electrospray Ionization (IR-MALDESI): From Fundamentals to New Directions
                        David C. Muddiman
                        Agilent Technologies, Santa Clara, CA 2019
                      4. 267. Infrared Matrix-Assisted Laser Desorption Electrospray Ionization (IR-MALDESI) as a Novel Platform for Molecular Microscopy
                        David C. Muddiman
                        Asilomar Meeting on Mass Spectrometry, Pacific Grove, CA 2019
                      5. 266. Innovations in Chemistry and Mass Spectrometry Platform Technologies and Their Application to Diverse Biological Problems
                        David C. Muddiman
                        Seton Hall University, South Orange, NJ 2019
                      6. 265. Innovations in Chemistry and Mass Spectrometry Platform Technologies and Their Application to Diverse Biological Problems
                        David C. Muddiman
                        University of British Columbia, Vancover, Canada 2019
                      7. 264. Innovations in Chemistry and Mass Spectrometry Platform Technologies and Their Application to Diverse Biological Problems
                        David C. Muddiman
                        The European Molecular Biology Laboratory, Heidleberg, Germany 2019
                      8. 263. Matrix-Assisted Laser Desorption Electrospray Ionization (MALDESI): Background, Potential, and Limitations
                        David C. Muddiman
                        Abbvie Inc, Chicago, IL 2019
                      9. 262. Innovations in Chemistry and Mass Spectrometry Platform Technologies and Their Application to Diverse Biological Problems
                        David C. Muddiman
                        Department of Biochemistry, NC State University, Raleigh, NC 2019
                      10. 261. Innovations in Chemistry and Mass Spectrometry Platform Technologies and Their Application to Diverse Biological Problems
                        David C. Muddiman
                        Brigham Young University, Provo, UT 2019
                      11. 260. Innovations in Chemistry and Mass Spectrometry Platform Technologies for Quantitative Glycomics
                        David C. Muddiman, Jaclyn Gowen, James Dodds, Erin S. Baker, Daniel M. Rotroff, James N. Petitte, Alison A. Motsinger-Reif, Michael MacCoss, Thomas Montine
                        15th Annual Conference of the United States Human Proteome Organization: Proteomics at the Frontier of Biology and Medicine, Rockville, MD 2019

              2018Back to top

                      1. 259. New Advances in IR-MALDESI for Mass Spectrometry Imaging
                        David C. Muddiman
                        IMSS II and OurCon VI, Charleston, SC 2018
                      2. 258. Innovations in Chemistry and Mass Spectrometry Platform Technologies for SystemsLevel Measurements
                        David C. Muddiman
                        Thermo Fisher Scientific, San Jose, CA 2018
                      3. 257. Innovations in Chemistry and Mass Spectrometry Platform Technologies for
                        Quantitative Glycomics
                        David C. Muddiman
                        Understanding the Role of Glycosylation in Alzheimer’s Disease, Division of
                        Neuroscience, National Institute on Aging, Bethesda, Maryland 2018
                      4. 256. Innovations in Chemistry and Mass Spectrometry Platform Technologies for SystemsLevel Measurements
                        David C. Muddiman
                        Department of Molecular Biomedical Sciences, College of Veterinary Medicine, North
                        Carolina State University 2018
                      5. 255. Innovations in Mass Spectrometry Platform Technologies to Address Diverse Biological
                        Research Hypotheses
                        David C. Muddiman
                        James Madison University, Harrisonburg, VA 2018
                      6. 254. Development and Application of IR-MALDESI for 2D and 3D Imaging
                        David C. Muddiman
                        The Pittsburgh Conference, Orlando, FL 2018
                      7. 253. Development of INLIGHT for Quantiative Glycomics
                        David C. Muddiman
                        The Pittsburgh Conference, Orlando, FL 2018
                      8. 252. IR MALDESI: from Technological Innovations to Cancer, HIV Treatment and Exposomics
                        David C. Muddiman
                        Mass Spectrometry Applications to the Clinical Laboratory, Palm Springs, CA 2018
                      9. 251. Innovations in Mass Spectrometry Platform Technologies for Epithelial Ovarian Cancer Research and High Throughput Screenings
                        David C. Muddiman
                        Washington Chromatography Discussion Group, Rockville, MD 2018

              2017Back to top

                      1. 250. IR-MALDESI: An Innovative Approach to Molecular Microscopy
                        David C. Muddiman
                        Temple University, Philadelphia, PA 2017
                      2. 249. IR-MALDESI: An Innovative Mass Spectrometry Imaging Platform Technology
                        David C. Muddiman
                        SERMACS, Charlotte, NC 2017
                      3. 248. IR-MALDESI: An Innovation Approach to Molecular Microscopy
                        David C. Muddiman
                        NIEHS, Research Triangle Park, NC 2017
                      4. 247. Innovative Mass Spectrometry Chemistries and Technologies to Read the Complex Language of Biology
                        David C. Muddiman
                        East China Normal University, Shanghai, China 2017
                      5. 246. Innovative Mass Spectrometry Chemistries and Technologies to Read the Complex Language of Biology
                        David C. Muddiman
                        Dalian Institute of Chemical Physics, Dalian, China 2017
                      6. 245. Novel Discoveries in Ovarian Cancer and ALS: From Proteome Profiling to Proteoforms
                        David C. Muddiman
                        Stockholm University, Stockholm, Sweden in November 2017
                      7. 244. Innovative Mass Spectrometry Approaches to Unravel Biology
                        David C. Muddiman
                        Department of Plant and Microbial Biology, NC State University 2017
                      8. 243. Novel Discoveries in Ovarian Cancer and ALS: From Proteome Profiling to Proteoforms
                        David C. Muddiman
                        Montreal Mass Spectrometry Discussion Group, Montreal, Canada 2017
                      9. 242. Chemical and Mass Spectrometry Strategies Enabling Human Health Biological Discoveries
                        David C. Muddiman
                        Cambridge Isotope Laboratories, Tewksbury, MA 2017
                      10. 241. Elucidation of Novel Proteoforms of Superoxide Dismutase (SOD1) in Sporadic ALS Patients
                        David C. Muddiman
                        United States Human Proteome Organization, San Diego, CA 2017
                      11. 240. Novel Discoveries in Ovarian Cancer and ALS: From Proteome Profiling to Proteoforms
                        David C. Muddiman
                        OMICS Strategies to Study the Proteome, Breckenridge, CO 2017

              2016Back to top

                      1. 239. Elucidation of Novel Proteoforms of Superoxide Dismutase (SOD1) in Sporadic ALS Patients
                        David C. Muddiman
                        Thermo Fisher Scientific Seminar Series, Bethesda, MD 2016
                      2. 238. Innovative Chemistries and Technologies to Read the Complex Language of Biology
                        David C. Muddiman
                        Washington-Baltimore Mass Spectrometry Discussion Group, Vendor Night, Columbia, MD 2016
                      3. 237. TransOMICS: From Innovative Technology and Model Organisms to Biological Impact
                        David C. Muddiman
                        Department of Molecular Science and BioDesign Institute, Arizona State University, Tempe, AZ 2016
                      4. 236. IR-MALDESI Mass Spectrometry Imaging of Complex Chemical and Biological Systems
                        David C. Muddiman
                        252nd National American Chemical Society Meeting and Exposition, Philadelphia, PA 2016
                      5. 235. TransOMICS: Integration of IR-MALDESI MSI with LMD Proteomics Data
                        David C. Muddiman
                        International Mass Spectrometry Conference, Toronto, Canada 2016
                      6. 234. IR MALDESI: A Novel Molecular Microscopy Method to Determine Drug Distributions in Tissues
                        David C. Muddiman
                        Analytica 2016, Munich, Germany 2016
                      7. 233. IR-MALDESI: An Innovative Approach to Molecular Microscopy
                        David C. Muddiman
                        Mass Spectrometry Applications to the Clinical Laboratory, Palm Springs, CA 2016
                      8. 232. IR-MALDESI: An Innovation Approach to Molecular Microscopy
                        David C. Muddiman
                        Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 2016

              2015Back to top

                      1. 231. Working Around the Cluck: A Systems Biology Approach to Understand the Origin and Biology of Ovarian Cancer
                        David C. Muddiman
                        Cancer Center, University of Arkansas, Little Rock, AR 2015
                      2. 230. Innovative Molecular Analysis Technologies to Unravel Complex Biological Questions,
                        David C. Muddiman
                        Central North Carolina American Chemical Society, Syngenta, Greensboro, NC 2015
                      3. 229. Working Around the Cluck: A Systems Biology Approach to Understand the Origin and Biology of Ovarian Cancer
                        David C. Muddiman
                        Department of Biochemistry and Biophysics, University of North Carolina Chapel Hill,
                        Chapel Hill, NC
                        2015
                      4. 228. Innovative Molecular Analysis Technologies to Unravel Complex Biological Questions,
                        David C. Muddiman
                        Department of Chemistry, Iowa State University, Ames, IA 2015
                      5. 227. Working Around the Cluck: A Systems Biology Approach to Understand the Origin and Biology of Ovarian Cancer
                        David C. Muddiman
                        Institute for Systems Biology, Seattle, WA 2015
                      6. 226. Innovative Molecular Analysis Technologies to Unravel Complex Biological Systems
                        David C. Muddiman
                        Bay Area Mass Spectrometry Discussion Group, Foster City, CA 2015
                      7. 225. The Importance of Ultrahigh Specificity in Reading the Complex Language of Biology
                        David C. Muddiman
                        The Pittsburgh Conference, New Orleans, LA 2015
                      8. 224. The Importance of Ultrahigh Specificity in Reading the Complex Language of Biology
                        David C. Muddiman
                        United States Human Proteome Organization, Tempe, AZ 2015

              2014Back to top

                      1. 223. Discovery of N-Linked Glycan Biomarkers in Domestic Hen Model of Ovarian Cancer using INLIGHT™ Strategy
                        David C. Muddiman
                        6th Annual Meeting of the Proteomics Society, India Institute of Technology, Mumbai, India, 2014
                      2. 222. Quantitative Mass Spectrometry Imaging (QMSI) by a Novel IR-MALDESI Approach
                        David C. Muddiman
                        6th Annual Meeting of the Proteomics Society, India Institute of Technology, Mumbai, India, 2014
                      3. 221. Mapping HIV Drug Distributions using a Novel Mass Spectrometry Imaging Source
                        David C. Muddiman
                        American Association for Pharmaceutical Sciences, San Diego, CA 2014
                      4. 220. Development of a Novel Atmospheric Pressure Ionization Source for Biological and Chemical Imaging
                        David C. Muddiman
                        SERMACS, Nashville, TN 2014
                      5. 219. Quantitatively Controlling Chaos: The N-Linked Glycome of an Integrated Systems Biology Approach to Understanding Ovarian Cancer Initiation and Progression
                        David C. Muddiman
                        Asilomar Conference, Advances in Glycomics and Glycoproteomics: Methods and Applications, Pacific Grove, CA 2014
                      6. 218. Matrix-Assisted Laser Desorption Electrospray Ionization (MALDESI): From Fundamentals to Tissue and Chemical Imaging
                        David C. Muddiman
                        248th ACS National Meeting, San Francisco, CA 2014
                      7. 217. Quantitatively Controlling Chaos: Adventures in Absolute Protein Quantification
                        David C. Muddiman
                        Cold Spring Harbor Laboratory, Long Island, NY 2014
                      8. 216. Thing 1 and Thing 2 (and Thing 3): ESI, MALDI and Hybrids of the Two
                        David C. Muddiman
                        Cold Spring Harbor Laboratory, Long Island, NY 2014
                      9. 215. Mapping HIV Drugs in Tissue using IR-MALDESI MSI Coupled to the Q-Exactive with Several Acquisition Modes
                        David C. Muddiman, Jeremy A. Barry, Guillaume Robichaud, Mark Bokhart, Elias Rosen, Milad Nazari, Troy Ghashghaei, Corbin Thompson, Craig Sykes, and Angela Kashuba
                        62nd ASMS Conference on Mass Spectrometry and Allied Topics, Baltimore, MD 2014
                      10. 214. Development of the INLIGHT™ Strategy for the Relative Quantification of N-Linked Glycans using Different Separation Modes
                        David C. Muddiman, Amber C. Cook, James P. McCord, Liangliang Sun, Norman J. Dovichi
                        HPLC 2014, New Orleans, LA 2014
                      11. 213. Quantitatively Controlling Chaos: The New Biology
                        David C. Muddiman
                        Triangle Area Mass Spectrometry Discussion Group, Genome Sciences, UNC Chapel Hill 2014
                      12. 212. Infrared MALDESI Imaging Source Coupled to Q-Exactive for Discovery-Based and Targeted Analysis of Endogenous and Exogenous Species in Tissues
                        David C. Muddiman
                        Frontiers in Instrumentation, 10th Annual United States Human Proteome Organization, Seattle, WA 2014
                      13. 211. Quantitative and Comprehensive Chemistry and Technology: THE NEW BIOLOGY
                        David C. Muddiman
                        Arizona Mass Spectrometry Discussion Group, Tucson, AZ 2014
                      14. 210. Development of the INLIGHT™ Strategy for the Relative Quantification of N-Linked Glycans in Complex Biospecimens
                        David C. Muddiman
                        The Pittsburgh Conference, Chicago, IL 2014
                      15. 209. Quantitative and Comprehensive Chemistry and Technology: THE NEW BIOLOGY
                        David C. Muddiman
                        Eastern Virginia Medical School, Norfolk, VA 2014
                      16. 208. Innovative Chemical and Instrumental Approaches Directed at Unraveling Complex Biological Systems
                        David C. Muddiman
                        Department of Chemistry and Biochemistry, University of North Carolina at Greensboro, Greensboro, NC 2014
                      17. 207. Innovative Chemical and Instrumental Approaches Directed at Unraveling Complex Biological Systems
                        David C. Muddiman
                        Department of Chemistry, University of Alberta, Edmonton, AL 2014

              2013Back to top

                      1. 206. Development of Novel Chemical and Instrumental Methods using Design of Experiments for Quantitative Proteomic, Glycomic, Metabolomic, and Lipidomic Measurements in Complex Biological Systems
                        David C. Muddiman
                        Department of Chemistry and Chemical Biology, Northeastern University, Boston, MA 2013
                      2. 205. Development and Application of the INLIGHT Relative Quantification Strategy: From Monitoring Glycostasis to Early Detection of Ovarian Cancer
                        David C. Muddiman
                        Boston Glycobiology Discussion Group, Boston University Medical Campus, Boston, MA 2013
                      3. 204. Fundamentals and Applications of Infrared Matrix-Assisted Laser Desorption Electrospray Ionization Source for Mass Spectrometry Imaging
                        David C. Muddiman
                        246th ACS National Meeting, Indianapolis, IN 2013
                      4. 203. Individuality Normalization and Labeling with Isotopic Glycan Hydrazide Tags (INLIGHT): A Novel Glycan Relative Quantification Strategy, Development and Application
                        David C. Muddiman, S. Hunter Walker, Amber C. Cook, Amber D. Taylor
                        Cold Spring Harbor Laboratory, Long Island, NY 2013
                      5. 202. Mass Spectrometry-Based Absolute Protein Quantification
                        David C. Muddiman and Philip L. Loziuk
                        Cold Spring Harbor Laboratory, Long Island, NY 2013
                      6. 201. Electrospray Ionization, Matrix-Assisted Laser Desorption Ionization, and Hybrid of the Two: From Mechanisms to Imaging
                        David C. Muddiman, Jeremy A. Barry, and Guillaume Robichaud
                        Cold Spring Harbor Laboratory, Long Island, NY 2013
                      7. 200. Proteolysis and Peptide Decay: Considerations for Discovery and Targeted Proteomic Workflows with Applications to Systems Modeling of Lignin and Cellulose Biosynthesis
                        David C. Muddiman and Philip L. Loziuk
                        American Society for Mass Spectrometry, Minneapolis, MN 2013
                      8. 199. Innovations and Findings in Academic Research: Translating them to the Pharmaceutical Industry
                        David C. Muddiman
                        GlaxoSmithKline, Worldwide VTC, RTP, NC 2013

              2012Back to top

                      1. 198. N-Linked Glycan Hydrophobic Tagging, Profiling, and Relative Quantification Strategy Toward Biomarker Discovery Efforts in the Hen Model of Spontaneous Ovarian Cancer
                        David C. Muddiman
                        National Institutes of Health, Innovative Molecular Analysis Technologies Meeting, Houston, TX 2012
                      2. 197. Chemical and Synthetic Biology Approaches for Polyketide Diversification
                        G. Williams, J. McArthus, S. Randall, M. Draelos, E.M. Musiol, Z. Ye, C. Ladner, D.C. Muddiman, T. Weber
                        Southeastern Regional Meeting of the American Chemical Society, Raleigh, NC 2012
                      3. 196. Ambient Tissue Imaging using Infrared Matrix-Assisted Laser Desorption Electrospray Ionization Mass Spectrometry
                        David C. Muddiman
                        Southeastern Regional Meeting of the American Chemical Society, Raleigh, NC 2012
                      4. 195. New Chemical and Instrumental Tools for Quantitatively Exploring the N-Linked Glycome
                        David C. Muddiman
                        Boston Glycobiology Discussion Group, Boston, MA 2012
                      5. 194. Development of Novel Chemical and Instrumental Methods using Design of Experiments for Quantitative Proteomic Measurements in Complex Biological Systems
                        David C. Muddiman
                        Department of Chemistry, Brandeis University, Boston, MA 2012
                      6. 193. N-linked Glycan Profiling Strategy Toward Biomarker Discovery Efforts in the Hen Model of Spontaneous Ovarian Cancer
                        David C. Muddiman and S. Hunter Walker
                        4th Charles Warren Workshop, CCRC, University of Georgia, Athens, GA 2012
                      7. 192. MALDI, ESI and Hybrids of the Two
                        David C. Muddiman, Jeremy A. Barry, and Guillaume Robichaud
                        Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 2012
                      8. 191. Mass Spectrometry-based Absolute Protein Quantification
                        David C. Muddiman and Christopher M. Shuford
                        Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 2012
                      9. 190. The Impact of Fourier Transform Mass Spectrometry on Biological Research
                        David C. Muddiman
                        The Pittsburgh Conference, Orlando, FL 2012 (Award Symposium Honoring Alan Marshall)
                      10. 189. Proteomics and Glycomics Tools for the Study of Human Disease
                        David C. Muddiman
                        GlaxoSmithKline, King of Prussia, PA 2012
                      11. 188. N-Linked Glycan Hydrophobic Tagging, Profiling, and Relative Quantification Strategy Toward Biomarker Discovery Efforts in the Hen Model of Spontaneous Ovarian Cancer
                        David C. Muddiman
                        National Institutes of Health, Innovative Molecular Analysis Technologies Meeting, Houston, TX 2012
                      12. 187. Chemical and Synthetic Biology Approaches for Polyketide Diversification
                        G. Williams, J. McArthus, S. Randall, M. Draelos, E.M. Musiol, Z. Ye, C. Ladner, D.C. Muddiman, T. Weber
                        Southeastern Regional Meeting of the American Chemical Society, Raleigh, NC 2012
                      13. 186. Ambient Tissue Imaging using Infrared Matrix-Assisted Laser Desorption Electrospray Ionization Mass Spectrometry
                        David C. Muddiman
                        Southeastern Regional Meeting of the American Chemical Society, Raleigh, NC 2012
                      14. 185. New Chemical and Instrumental Tools for Quantitatively Exploring the N-Linked Glycome
                        David C. Muddiman
                        Boston Glycobiology Discussion Group, Boston, MA 2012
                      15. 184. Development of Novel Chemical and Instrumental Methods using Design of Experiments for Quantitative Proteomic Measurements in Complex Biological Systems
                        David C. Muddiman
                        Department of Chemistry, Brandeis University, Boston, MA 2012
                      16. 183. N-linked Glycan Profiling Strategy Toward Biomarker Discovery Efforts in the Hen Model of Spontaneous Ovarian Cancer
                        David C. Muddiman and S. Hunter Walker
                        4th Charles Warren Workshop, CCRC, University of Georgia, Athens, GA 2012
                      17. 182. MALDI, ESI and Hybrids of the Two
                        David C. Muddiman, Jeremy A. Barry, and Guillaume Robichaud
                        Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 2012
                      18. 181. Mass Spectrometry-based Absolute Protein Quantification
                        David C. Muddiman and Christopher M. Shuford
                        Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 2012
                      19. 180. The Impact of Fourier Transform Mass Spectrometry on Biological Research
                        David C. Muddiman
                        The Pittsburgh Conference, Orlando, FL 2012 (Award Symposium Honoring Alan Marshall)
                      20. 179. Proteomics and Glycomics Tools for the Study of Human Disease
                        David C. Muddiman
                        GlaxoSmithKline, King of Prussia, PA 2012

              2011Back to top

                      1. 178. Novel Reagents to Probe the N-Linked Glycome for the Study of Spontaneous EOC in the Chicken Model
                        David C. Muddiman
                        Innovative Molecular Analysis Technologies, National Cancer Institute, Bethesda, MD 2011
                      2. 177. New Chemical and Instrumental Tools for Exploring the Proteome and Glycome
                        David C. Muddiman
                        Department of Chemistry, Brown University, Providence, RI 2011
                      3. 176. From Innovative Technologies to Model Organisms: The Search for Biomarkers for the Detection of Early Stage Epithelial Ovarian Cancer
                        David C. Muddiman
                        UW- Madison Human Proteomics Symposium, Madison, WI 2011
                      4. 175. Characterization of the UV- and IR-Matrix-Assisted Laser Desorption Ionization (MALDESI) Source with Integrated RASTIR
                        MARM of the American Chemical Society, College Park, MD 2011
                      5. 174. Innovative Approaches to Proteomics and Glycomics Research
                        David C. Muddiman
                        Department of Chemistry and Biochemistry, The Ohio State University, Columbus, OH 2011
                      6. 173. Intra- and Inter-Individual Variability of Plasma Proteins in the Chicken Model of Spontaneous Epithelial Ovarian Cancer via Selected Reaction Monitoring
                        Adam Hawkridge; Genna Andrews; James Petitte; David C. Muddiman
                        7th Annual United State Human Proteome Organization Meeting, Raleigh, NC 2011
                      7. 172. Innovative Approaches to Proteomics and Glycomics Research
                        David C. Muddiman
                        Department of Chemistry and Biochemistry, University of North Carolina-Greensboro, North Carolina 2011
                      8. 171. Innovation and Application of Proteomics and Glycomics Strategies Directed at Epithelial Ovarian Cancer
                        David C. Muddiman
                        The Scripps Research Institute, Jupiter, Florida, 2011

              2010Back to top

                      1. 170. Development of Novel Strategies for Proteomics and Glycomics Research
                        David C. Muddiman
                        Eastern Analytical Symposium Honoring Richard D. Smith, 2010 EAS Awardee for Outstanding Achievements in the Fields of Analytical Chemistry, East Somerset, New Jersey,
                        2010
                      2. 169. Matrix-Assisted Laser Desorption Electrospray Ionization: Mechanisms, Technology, and Application
                        David C. Muddiman
                        26th Asilomar Conference on Mass Spectrometry, Pacific Grove, CA, 2010
                      3. 168. Development and Application of Mass Spectrometry-Based Biomarker Discovery Technologies for the Early Detection of Epithelial Ovarian Cancer
                        David C. Muddiman
                        The University of Texas Health Science Center at San Antonio, San Antonio, TX, 2010
                      4. 167. Development and Application of Mass Spectrometry-Based Biomarker Discovery Technologies for the Early Detection of Epithelial Ovarian Cancer
                        David C. Muddiman
                        Texas A&M; University, College Station, TX, 2010
                      5. 166. Matrix-Assisted Laser Desorption Electrospray Ionization (MALDESI)
                        David C. Muddiman
                        Precision Engineering Center, Monteith Engineering Research Center, North Carolina State University, Raleigh, NC, 2010
                      6. 165. New Ionization Methods for Large-Molecule Top-Down Mass Spectrometry
                        David C. Muddiman
                        United States Human Proteome Organization, Denver, CO, 2010
                      7. 164. Proteomics and Glycomics Approaches to Elucidate Biomarkers for the Early Detection of Ovarian Cancer
                        David C. Muddiman
                        PittCon 2010, Orlando, Florida, 2010

              2009Back to top

                      1. 163. Development and Application of Chemical and Instrumental Approaches Directed at Biomarker Discovery
                        David C. Muddiman
                        Department of Chemistry, Louisiana State University, Baton Rouge, LA, 2009
                      2. 162. Development and Application of Chemical and Instrumental Approaches Directed at Biomarker Discovery
                        David C. Muddiman
                        Department of Chemistry, George Washington University, Washington, DC, 2009
                      3. 161. Developing Novel Hybrid Ionization Sources Around the MALDESI Technology Platform
                        Adam M. Hawkridge and David C. Muddiman
                        Federation of Analytical Chemistry and Spectroscopy Societies, Louisville, KY, 2009
                      4. 160. Mass Spectrometry-Based Biomarker Discovery: Towards a Global Proteome Index-of-Individuality
                        David C. Muddiman and Adam M. Hawkridge
                        Pharmaceutical and Biomedical Analysis, Orlando, FL, 2009
                      5. 159. The Development of an Aerodynamic Focusing Device, the Air Amplifier, for Improved Biomarker Analyses by Mass Spectrometry
                        David C. Muddiman, R. Brent Dixon, Amarnatha S. Potturi, Dan Cassidy, Jack R. Edwards, Alex Sohn, Guillaume Robichaud, Thomas A. Dow
                        NCI IMAT Grantee Meeting, Bethesda, MD, 2009
                      6. 158. Rationale Ovarian Cancer Biomarker Discovery: The Importance of Longitudinal Experimental Designs
                        David C. Muddiman
                        ADAPT Congress, Washington, DC, 2009
                      7. 157. Cancer Biomarker Discovery and Quantification using Mass Spectrometry
                        David C. Muddiman
                        Precision Engineering Center, Monteith Engineering Research Center, North Carolina State University, Raleigh, NC, 2009
                      8. 156. Development and Application of Chemical and Instrumental Approaches Directed at Biomarker Discovery
                        David C. Muddiman
                        Department of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, NC, 2009
                      9. 155. Ambient Ionization Methods Coupled to FTMS for Direct Analysis and Imaging Applications
                        David C. Muddiman
                        Center for Analytical and Instrumentation Development, Purdue University, West Lafayette, IN, 2009
                      10. 154. Development of Atmospheric Pressure Ionization Sources Coupled to FT-ICR Mass Spectrometry for the Characterization of Biological Molecules
                        David C. Muddiman, Jason S. Sampson, K.K. Murray, R.B. Dixon
                        7th North American FT MS Conference, Key West, FL, 2009
                      11. 153. Development and Application of FT-ICR Mass Spectrometry for Proteomics and Glycomics Research
                        BASF, The Chemical Company, Research Triangle Park, NC, 2009
                      12. 152. Aligning Chemistry and High End Mass Spectrometry with Important Clinical Problems: Building a Strong Foundation Based on Interdisciplinary Collaborations
                        David C. Muddiman
                        Department of Chemistry, UNC Chapel Hill, Chapel Hill, NC, 2009
                      13. 151. Integration of Engineering, Chemistry, and Medicine: Progress Towards the Molecular Characterization of Cancer
                        David C. Muddiman
                        Department of Chemistry, NC A & T University, Greensboro, NC, 2009

              2008Back to top

                      1. 150. Innovative Ionization Sources for Imaging Mass Spectrometry
                        David C. Muddiman
                        Department of Chemistry, Georgia Institute of Technology, Atlanta, GA, 2008
                      2. 149. A Combinatorial Approach: The Use of MALDI-MS and Nano LC-MS for Glycan Biomarker Discovery
                        David C. Muddiman
                        Diosynth Biotechnology, Cary, NC, 2008
                      3. 148. New Ionization Sources for Biological Mass Spectrometry
                        David C. Muddiman
                        Asilomar Conference on Mass Spectrometry, New Methods, Instrumentation, and Applications of Ion Traps, Pacific Grove, CA, 2008
                      4. 147. Time-of-Flight Mass Analyzers: Single-Ion Counting versus ADC Detection
                        David C. Muddiman
                        US LC/MS Innovations Seminar Tour, Agilent Technologies, Durham, NC, 2008
                      5. 146. Innovative Technology Development Directed at the Elucidation of Biomarkers for the Detection of Early-State Ovarian Cancer
                        Taufika I. Williams, Michael S. Bereman, D. Keith Williams, Kimberly K. Kalli, William A. Cliby and David C. Muddiman
                        National Cancer Institute, Innovative Molecular Analysis Technologies, Cambridge, MA, 2008
                      6. 145. A Combinatorial Approach: The Use of MALDI-MS and Nano LC-MS for Glycan Biomarker Discovery
                        Taufika Islam Williams, Michael S. Bereman, Kimberly A. Kalli, William A. Cliby and David C. Muddiman
                        Sixth Annual Protein Biomarkers Conference, Philadelphia, PA, 2008
                      7. 144. Driving Research with a Multidisciplinary Approach
                        David C. Muddiman
                        Bioinformatics and Bioengineering Summer Institute, Virginia Commonwealth University, Richmond, VA, 2008
                      8. 143. Glycan Profiling in Plasma: Fundamentals and Applications to Ovarian Cancer
                        Taufika Islam Williams and David C. Muddiman
                        The Pittsburgh Conference, New Orleans, LA, 2008

              2007Back to top

                      1. 142. Mass Spectrometry Detection Techniques Available for Qualitative and Quantitative Assays – Small vs. Large Molecules
                        David C. Muddiman
                        American Association of Pharmaceutical Scientists, San Diego, CA, 2007
                      2. 141. Fundamentals and Applications of DESI and MALDESI Coupled to FT-ICR-MS
                        David C. Muddiman
                        Workshop on The Art of Open Air Ionization on Surfaces, Philadelphia, PA, November 8-9, 2007
                      3. 140. Plasma Biomarker Discovery and Analysis using FT-ICR Mass Spectrometry
                        David C. Muddiman, Adam Hawkridge, Taufika I. Williams, William Cliby, and John Burnett
                        Federation of Analytical Chemistry and Spectroscopy Societies Memphis, TN, 2007
                      4. 139. Development of Hybrid Atmospheric Ionization Sources for Direct Analysis of Macromolecules by FT-ICR-MS
                        David C. Muddiman, Adam Hawkridge, Jason S. Sampson, Michael S. Bereman and R. Brent Dixon
                        Federation of Analytical Chemistry and Spectroscopy Societies Memphis, TN, 2007
                      5. 138. New Mass Spectrometric Proteomic Technologies
                        David C. Muddiman
                        Metabolomics and Proteomics Seminar Series, Department of Biochemistry, University of Minnesota, St. Paul, MN, 2007
                      6. 137. Advancing Quantitative Proteomics Technologies
                        David C. Muddiman
                        Minnesota Mass Spectrometry Discussion Group, Minneapolis, MN, 2007
                      7. 136. Chemical and Mass Spectrometry Advances for Improved Clinical Proteomic Measurements David C. Muddiman
                        Department of Chemistry, University of Michigan, Ann Arbor, MI, 2007
                      8. 135. nanoRP-HPLC and SCX-nanoRP-HPLC coupled to FT-ICR Mass Spectrometry to Effectively Address Complex Biological Mixtures
                        David C. Muddiman
                        Triangle Chromatography Discussion Group Symposium, Raleigh, NC, 2007
                      9. 134. Statistical Issues in Mass Spectrometry Based Proteomics
                        David C. Muddiman
                        Department of Statistics, North Carolina State University, Raleigh, NC, 2007
                      10. 133. Innovations and Applications of the LTQ-FT in the Biological Arena
                        David C. Muddiman
                        ThermoElectron Users Meeting, Cincinnati, OH, 2007
                      11. 132. Innovations and Applications of the LTQ-FT in the Biological Arena
                        David C. Muddiman
                        ThermoElectron Users Meeting, Chicago, IL, 2007
                      12. 131. Novel Chemical and Instrumental Approaches to Effectively Address Clinical Proteomic Problems
                        David C. Muddiman
                        Department of Chemistry, Vanderbilt University, Nashville, TN, 2007
                      13. 130. Innovations in Ion Sources for Biological FT-ICR Mass Spectrometry
                        David C. Muddiman
                        6th North American FT-ICR MS Conference, Lake Tahoe, CA, 2007
                      14. 129. Innovations and Applications of the LTQ-FT in the Biological Arena
                        David C. Muddiman
                        ThermoElectron Users Meeting, Lake Tahoe, CA, 2007
                      15. 128. Effectively Addressing Clinical Proteomic Problems using Novel Chemical and Instrumental Approaches
                        David C. Muddiman
                        Department of Pharmaceutics, Virginia Commonwealth University, Richmond, VA, 2007

              2006Back to top

                      1. 127. Traps, TOF’s and Triples Applied to Global and Targeted Clinical Proteomics
                        David C. Muddiman
                        Divisions of Molecular Pharmaceutics and Medicinal Chemistry, University of North Carolina-Chapel Hill, Chapel Hill, NC, 2006
                      2. 126. Selective Chemistry and Advancing Mass Spectrometry Instrumentation to Effectively Approach Challenging Clinical Questions
                        David C. Muddiman and Adam M. Hawkridge
                        Department of Chemistry, Georgia Institute of Technology, Atlanta, GA, 2006
                      3. 125. Novel Chemical and Instrumental Approaches Coupled to ESI-FT-ICR Mass Spectrometry to Effectively Address Proteomics Questions
                        David C. Muddiman
                        Department of Genome Sciences, University of Washington, Seattle, WA, 2006
                      4. 124. Development of nLC-dualESI-FT-ICR MS and it Applications in Cancer and Cardiovascular Plasma Proteomics
                        David C. Muddiman and Adam M. Hawkridge
                        Federation of Analytical Chemistry and Spectroscopy Societies Lake Buena Vista, FL, 2006
                      5. 123. A Primer and Update on the Current State of Large Molecule Quantification
                        David C. Muddiman
                        Applied Pharmaceutical Analysis, The Boston Society for Advanced Therapeutics, Boston, MA, 2006
                      6. 122. FT-ICR Mass Spectrometry: Putting a High Resolving Power Spin on Protein Identification and Quantification
                        David C. Muddiman, Adam H. Hawkridge, Kenneth L. Johnson, and H. Robert Bergen III
                        231st National American Chemical Society Meeting, Symposium Honoring Richard Caprioli, Recipient of the 2006 Field and Franklin Award, Atlanta, GA, 2006

              2005Back to top

                      1. 121. Putting a High Resolving Power Spin on Proteomics in the Clinical Domain
                        David C. Muddiman
                        ThermoElectron Proteomics Series, Atlanta, GA, 2005
                      2. 120. Fourier Transform Ion Cyclotron Resonance Mass Spectrometry: Putting a High Resolving Power Spin on Macromolecular Ions
                        David C. Muddiman
                        Department of Chemistry, East Carolina University, Greenville, NC, 2005
                      3. 119. Putting a High Resolving Power Spin on Proteomics in the Clinical Domain
                        David C. Muddiman
                        ThermoElectron Proteomics Series, Rochester, NY, 2005
                      4. 118. Protein Biomarker Discovery: A Tale of Technologies on a Journey Worth Making
                        David C. Muddiman
                        Department of Chemistry and Biochemistry, University of Maryland, College Park, MD, 2005
                      5. 117. Protein Biomarker Discovery in Plasma Based on FT-ICR Mass Spectrometry
                        David C. Muddiman
                        Department of Chemistry, University of Georgia, Athens, GA, 2005
                      6. 116. Ovarian Cancer Biomarker Discovery: A Tale of Technologies
                        David C. Muddiman
                        AACR/NCI/EORTC International Conference” Molecular Targets and Cancer Therapeutics: Discovery, Biology and Clinical Applications, Philadelphia, PA, 2005
                      7. 115. Aligning High-End Mass Spectrometry with the Clinical Laboratory: Baby Steps on a Journey Worth Making
                        David C. Muddiman
                        Mass Spectrometry in the Clinical Lab: Matching Technology to Application, American Association for Clinical Chemistry, Orlando, FL, 2005
                      8. 114. Identification and Relative and Absolute Quantification of Proteins using FT-ICR Mass Spectrometry
                        David C. Muddiman
                        Korean Research Institute of Standards and Technology, Taejon, Korea, 2005
                      9. 113. Traps, Triples and TOF’s in the Clinical Domain: Proteomics in the Medical Field
                        David C. Muddiman
                        Seoul University National Hospital, Seoul, Korea, 2005
                      10. 112. Traps, Triples and TOF’s in the Clinical Domain: Proteomics in the Medical Field
                        David C. Muddiman
                        Inje University Sanggye Paik Hospital, Seoul, Korea, 2005
                      11. 111. Implementation of nanoLC-FT-ICR Mass Spectrometry for Studying Circulating Forms of Brain Natriuretic Peptide in Congestive Heart Failure Patients
                        Adam M. Hawkridge, Denise M. Heublein, H. Robert Bergen III, John C. Burnett, Jr., David C. Muddiman
                        North American ICR Meeting, Key West, Florida, 2005
                      12. 110. The Utility of FT-ICR Mass Spectrometry in the Clinical Domain: From Discovery to Targeted Proteomics
                        David C. Muddiman
                        Trapped Ion Meeting, Oxford University, London, England, 2005
                      13. 109. Accurate Characterization of Nucleic Acids by FT-ICR Mass Spectrometry, LGC, Southwestern, England, 2005
                      14. 108. Unraveling the Low Molecular Weight Serum and Plasma Proteome using LC- FT-ICR MS: The Search for Biomarkers Predictive for Early Stage Ovarian and Pancreatic Cancer
                        David C. Muddiman, Adam H. Hawkridge, Kenneth L. Johnson, Ann L. Oberg, Christopher J. Mason, H. Robert Bergen III, William A. Cliby, Janet E. Olson
                        The Association of Biomolecular Resource Facilities, Savannah, GA, 2005
                      15. 107. Development of a Robust Biomarker Discovery Platform Based on LC-FT-ICR Mass Spectrometry
                        David C. Muddiman
                        Department of Chemistry, University of Massachusetts-Amherst, 2005
                      16. 106. Protein Marker Discovery in Plasma and Serum: At the Bleeding Edge of Measurement Science
                        David C. Muddiman
                        Department of Chemistry, Oregon State University, Corvallis, Oregon, 2005
                      17. 105. Clinical Proteomics: Making an Impact through the Chemistry Porthole and Building Diverse Research Teams
                        David C. Muddiman
                        Department of Chemistry, Carleton College, Northfield, Minnesota, 2005

              2004Back to top

                      1. 104. The Challenges and Opportunities of Bringing Proteomics into the Clinical Laboratory
                        David C. Muddiman
                        Endocrine Research Group, St. Mary’s Hospital, Rochester, MN, 2004
                      2. 103. Proteomic Measurements based on FT-ICR Mass Spectrometry: Challenges and Opportunities
                        David C. Muddiman
                        Proteome Society Meeting, London, Ontario, 2004
                      3. 102. Clinical Proteomics: At the Bleeding Edge of Measurement Science
                        David C. Muddiman
                        University of Western Ontario, London, Ontario, 2004
                      4. 101. Mass Spectrometry Based Proteomics: From Discovery to Translation
                        David C. Muddiman
                        Lillehei Heart Institute, University of Minnesota, Minneapolis, MN, 2004
                      5. 100. Targeted and Biomarker Discovery Proteomics using 1D and 2D LC FT-ICR Mass Spectrometry
                        David C. Muddiman
                        3M Corporation, Saint Paul, MN, 2004
                      6. 99. The Role and Impact of 1 and 2D-LC FT-ICR Mass Spectrometry in the Clinical Arena: From Fundamentals to Applications
                        David C. Muddiman
                        Philip Morris, Richmond Virginia, 2004
                      7. 98. Biomarker Discovery in Plasma and Serum: Establishment of a Powerful Platform based on High-Field Magnets
                        David C. Muddiman
                        Manfred W. Comfort Symposium, Radisson Hotel, Rochester, MN, 2004
                      8. 97. Translation of Proteomic Discoveries from the Basic Science to the Clinical Laboratory: The Challenges and Opportunities
                        David C. Muddiman
                        Keynote Speaker, American Motility Society Annual Meeting, 2004
                      9. 96. Biomarker Discovery using a nanoLC-dualESI FT-ICR Mass Spectrometry Platform
                        D.C. Muddiman
                        Protein Biomarkers 2004, Philadelphia, PA, 2004
                      10. 95. An Integrated Biomarker Discovery Platform Based on nanoLC-dual-ESI-FT-ICR Mass Spectrometry
                        A.M. Hawkridge, C.J. Mason, K.L. Johnson, H.R. Bergen, and D.C. Muddiman
                        31st Annual Federation of Analytical Chemistry and Spectroscopy Societies Meeting, Portland, OR, 2004
                      11. 94. Shining a High Resolving Power Spin on Biological Macromolecules
                        D.C. Muddiman
                        Arthur F. Findeis Award Lecture, American Chemical Society, Philadelphia, PA, 2004
                      12. 93. Detection of TTR Variants and Evaluation of siRNA in Mice as a Potential Therapy for Familial Amyloidosis
                        D.C. Muddiman
                        Amyloid Research Group, Mayo Clinic College of Medicine, Rochester, MN, 2004
                      13. 92. The Role of Modern Mass Spectrometry in 21st Century: Fundamental Developments and Emerging Applications
                        D.C. Muddiman
                        Young Mass Spectrometrists, American Society for Mass Spectrometry, Nashville, TN, 2004
                      14. 91. The Classical ER Transcriptional Pathway
                        T .C. Spelsberg, D.G. Monroe, F.J. Secreto, D.C. Muddiman, B.L. Riggs, S. Khosla
                        American Society for Bone and Mineral Research, Bethesda, Maryland, 2004
                      15. 90. Biomarker Discovery using High Performance Mass Spectrometry
                        David C. Muddiman
                        Cambridge Healthtech Institute’s Protein Biomarkers: HighEnd Mass Spectrometry, Philadelphia, PA, 2004.
                      16. 89. The Challenges and Opportunities of Doing Proteomics in a Single Cell
                        David C. Muddiman
                        Cambridge Healthtech Institute’s Eighth Annual Proteomics Meeting. Proteomics: Addressing Challenges in Proteomic Analysis, San Francisco, CA, 2004
                      17. 88. Comprehensive Proteomics: The Integration of High Performance Mass Spectrometry, Genomics and Bioinformatics to Improve Our Understanding of Disease
                        David C. Muddiman
                        J. Craig Venter Science Foundation Joint Technology Center, Rockville, MD, 2004
                      18. 87. Global and Targeted Proteomics using High Performance Mass Spectrometry
                        David C. Muddiman
                        Symposium on Genomic and Proteomic Approaches Toward the Understanding of Drug Addiction, Basic Research Center on Molecular and Cell Biology of Drug Abuse (MCBDA) at the University of Minnesota, Minneapolis, MN, 2004
                      19. 86. Proteomics at the Clinical Interface
                        David C. Muddiman
                        95th Annual Meeting of the Society of Neurological Surgeons, New Orleans, LA, 2004
                      20. 85. High Field LC-ESI FT-ICR Mass Spectrometry: From Gas-Phase Ion Chemistry to Clinical Applications
                        David C. Muddiman
                        Southern Illinois University, Carbondale, IL, 2004
                      21. 84. Biomarker Discovery: High Performance Mass Spectrometry
                        David C. Muddiman and Janet E. Olson
                        Pancreatic Cancer Annual SPORE Retreat, Mayo Clinic College of Medicine, Rochester, MN, 2004
                      22. 83. Protein Characterization in Biological Fluids using High Performance Mass Spectrometry
                        David C. Muddiman
                        St. Olaf College, Northfield, MN, 2004
                      23. 82. Nucleic Acid Analysis Using High Field FT-ICR Mass Spectrometry
                        David C. Muddiman
                        Keystone Symposium on Mass Spectrometry in Systems Biology, Santa Fe, NM, 2004
                      24. 81. Clinical Proteomics by Multidimensional Chromatography Coupled with ESI FT-ICR Mass Spectrometry
                        David C. Muddiman
                        The Pittsburgh Conference (Pittcon 2004), Chicago, IL, 2004
                      25. 80. Development of High Performance Mass Spectrometry to Address Complex Biological Problems
                        David C. Muddiman
                        University of St. Thomas, Minneapolis, MN, 2004
                      26. 79. LC-ESI-FT-ICR Mass Spectrometry: The Ultimate in Peak Capacity and Adaptability for Measuring Biological Molecules
                        David C. Muddiman
                        Department of Chemistry, University of Minnesota, Minneapolis, MN, 2004
                      27. 78. Unraveling Biological Complexity with High Performance Mass Spectrometry
                        David C. Muddiman
                        Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, 2004

              2003Back to top

                      1. 77. MS-Based Proteomics: Instrumentation and Clinical Applications
                        David C. Muddiman
                        Resident Lecture Series, Mayo Clinic College of Medicine, 2003
                      2. 76. Ovarian Cancer Biomarker Discovery using 1D and 2D LC-High Performance Mass Spectrometry
                        David C. Muddiman
                        Ovarian Cancer Research and Clinical Team, Mayo Clinic College of Medicine, 2003
                      3. 75. Targeted and Discovery Proteomics using High Performance Mass Spectrometry
                        David C. Muddiman
                        Clinical Biochemistry and Immunology, Mayo Clinic College of Medicine, 2003
                      4. 74. Clinical Proteomic Applications of LC-ESI-FT-ICR Mass Spectrometry
                        David C. Muddiman
                        Associated Regional and University Pathologists, Salt Lake City, Utah, 2003
                      5. 73. Fundamentals and Biological Applications of ESI-FT-ICR Mass Spectrometry
                        David C. Muddiman
                        Brigham Young University, Provo, Utah, 2003
                      6. 72. Multidimensional Chromatography ESI-FT-ICR Mass Spectrometry: The Ultimate Peak Capacity for Proteome Measurements
                        David C. Muddiman
                        The 35th Central Regional Meeting of the American Chemical Society, Pittsburgh, PA, 2003
                      7. 71. Beyond Genomics: The Promise of Proteomics
                        David C. Muddiman
                        Genomics in Clinical Practice, Genetic Testing: Past, Present and Future, Mayo School of Continuing Medical Education, Rochester, MN, 2003
                      8. 70. Comprehensive and Rational Ovarian Cancer Biomarker Discovery using High Performance Mass Spectrometry-Based Proteomics
                        David C. Muddiman
                        Women’s Cancer 2003: Merging Science and Care, Mayo Clinic Cancer Center, Rochester, MN, 2003
                      9. 69. Targeted and Global Proteomics by 1D and 2D LC-FT-ICR Mass Spectrometry
                        David C. Muddiman
                        American Society for Bone and Mineral Research Annual Meeting, Minneapolis, MN, 2003
                      10. 68. Clinical Proteomics using One and Two-Dimensional LC Coupled with High Field FT-ICR Mass Spectrometry
                        David C. Muddiman
                        Seminar at Medical College of Wisconsin, Milwaukee, WI, 2003
                      11. 67. Proteomics FT-ICR Style: A Tribute to John Fenn’s Invention
                        David C. Muddiman
                        Mary E. Kapp Lecturer, Virginia Commonwealth University, Richmond, VA, 2003
                      12. 66. Electrospray Ionization Mass Spectrometry of Proteins
                        David C. Muddiman
                        Research Workshop, Wisconsin Symposium III, DNA Conference, Visiting Faculty Member, University of Wisconsin-Madison Medical School, Madison, WI, 2003
                      13. 65. Electrospray Ionization Mass Spectrometry of Nucleic Acids: From DNA: Drug Binding to Genotyping
                        David C. Muddiman
                        Wisconsin Symposium III, DNA Conference, Visiting Faculty Member, University of Wisconsin-Madison Medical School, Madison, WI, 2003
                      14. 64. Comprehensive Proteomics in a Single Cell: Technology and Applications
                        David C. Muddiman
                        Minnesota Chromatography Forum, Minneapolis, MN, 2003
                      15. 63. Genomics and Comprehensive Proteomics in a Single Cell: Technology and Applications
                        David C. Muddiman
                        Eastern Tennessee Mass Spectrometry Discussion Group, Knoxville, TN, 2003
                      16. 62. Characterization of Transthyretin by LC-ESI-FT-ICR Mass Spectrometry
                        David C. Muddiman
                        University of Tennessee at Knoxville, Knoxville, TN, 2003
                      17. 61. Comprehensive Proteomics in a Single Cell
                        David C. Muddiman
                        Mayo Clinic Genetics Society, Mayo Clinic, 2003
                      18. 60. Genomic and Proteomic Measurements in a Single Cell
                        David C. Muddiman
                        4th North American ICR Conference, San Francisco, CA, 2003
                      19. 59. Comprehensive Proteomics Using 2DLC-ESI-FT-ICR
                        David C. Muddiman
                        Seminar at Mayo Clinic Jacksonville, Jacksonville, FL, 2003
                      20. 58. Comprehensive Proteomics in a Single Cell Using HPLC-FT-ICR-MS
                        David C. Muddiman
                        Seminar at 3M Corporation, St. Paul, MN, 2003
                      21. 57. DNA Diagnostics by Mass Spectrometry
                        David C. Muddiman
                        Molecular Genetics Development Meeting, Mayo Clinic, Rochester, MN, 2003
                      22. 56. Accurate, Sensitive and Quantitative Nucleic Acid Analyses by ESI-FT-ICR Mass Spectrometry
                        David C. Muddiman
                        The Cleveland Clinic Educational Foundation, Department of Cell Biology, Visiting Lecture Pro Tempore, Cleveland, OH, 2003
                      23. 55. ESI-FTICR Mass Spectrometry for Genomic and Proteomic Research: From Fundamentals to Clinically Important Applications
                        David C. Muddiman
                        Seminar at the University of California-Riverside, Riverside, CA, 2003
                      24. 54. Genetic Analysis by ESI-FTICR Mass Spectrometry
                        David C. Muddiman
                        Lab Automation 2003, Palm Spring, CA, 2003

              2002Back to top

                      1. 53. Genomic and Proteomic Characterization by ESI-FT-ICR Mass Spectrometry using IRMPD
                        David C. Muddiman
                        Seminar at the University of Minnesota, Minneapolis, MN, 2002
                      2. 52. ESI-FTICR Mass Spectrometry: From Genotyping to Phosphopeptide Mapping All in a Single Cell
                        David C. Muddiman
                        Seminar at the University of Wisconsin at Madison, Madison, WI, 2002
                      3. 51. Determining Allele Frequency for Single-Nucleotide Polymorphisms by Electrospray Ionization FTICR Mass Spectrometry
                        David C. Muddiman
                        Desorption 2002, Estes Park, CO, 2002
                      4. 50. From SIMS, ESCA and TOF-SIMS to Biological Chemistry: My Herculoid Experience
                        David C. Muddiman
                        Hercules’ Symposium Honoring his 70th Birthday, Nashville, TN, 2002
                      5. 49. Characterization of Biological Molecules by Electrospray Ionization FT-ICR Mass Spectrometry
                        David C. Muddiman
                        Mayo-Karolinska Metabolic & Nutrition Conference, Stockholm, Sweden, 2002
                      6. 48. Accurate, Sensitive and Comprehensive Characterization of Biological Molecules by ESI-FT-ICR Mass Spectrometry
                        David C. Muddiman
                        Delaware Valley Mass Spectrometry Discussion Group, Merck, West Point, PA, 2002
                      7. 47. Mass Spectrometry and Proteomics: Inseparable Partners
                        David C. Muddiman
                        Gannon University and Hamot Medical Center, Erie, PA, 2002
                      8. 46. High Performance Mass Spectrometry for the Study of Biological Complexity
                        David C. Muddiman
                        National Research Council of Canada, Halifax, Nova Scotia 2002 – A Canadian Invention for Canadian Research? (aka “The Great Halifax FTICR Caper”)
                      9. 45. Extensive Evaluation of Novel Sample Preparation Techniques For Using High Sensitivity Mass Measurements of Nucleic Acids Using ESI-FT-ICR Mass Spectrometry
                        Laura T. George (2001-2002 Ingraham Scholar) and David C. Muddiman
                        Richmond Chromatography Discussion Group, Richmond, VA, 2002
                      10. 44. Genomics and Proteomics to Gas-Phase Ion Chemistry: Potential Roles of FTICR Mass Spectrometry in the Post-Genome Era
                        David C. Muddiman
                        Mayo Clinic and Foundation, Rochester, MN, 2002
                      11. 43. Accurate Mass Tag – Isotope Coded Affinity Tag LC-ESI-FTICR-MS for Protein Identification and Quantification
                        David C. Muddiman
                        American Association of Pharmaceutical Scientists, Toronto, CA, 2002
                      12. 42. High Sensitivity and Mass Accuracy of Large Nucleic Acids
                        David C. Muddiman
                        Federation of Analytical Chemistry and Spectroscopy Societies, Providence, RI, 2002
                      13. 41. Genomics to Proteomics: Bridging the Transcriptome with Electrospray Ionization FTICR Mass Spectrometry
                        David C. Muddiman
                        Department of Chemistry, University of Pittsburgh, Pittsburgh, PA, 2002
                      14. 40. Novel, Sensitive and Rapid Approaches for Phosphopeptide Mapping
                        David C. Muddiman
                        Department of Physiology, Medical College of Virginia, Richmond, VA, 2002
                      15. 39. Mass Spectrometric Approaches to Investigate Biological Systems
                        David C. Muddiman
                        Molecular Biology of Cell Growth Meeting, Massey Cancer Center, Medical College of Virginia, Richmond, VA, 2002
                      16. 38. Electrospray Ionization FTICR Mass Spectrometry: A Powerful Platform for a Diverse Range of Post-Genome Applications
                        David C. Muddiman
                        Department of Pharmacology and Toxicology, University of Alabama, Birmingham, AL, 2002
                      17. 37. ‘High Throughput’ Genotyping of Length Polymorphisms by Mass Spectrometry: Forensic and Clinical Applications
                        David C. Muddiman
                        Lab Automation 2002, Palm Springs, CA, 2002

              2001Back to top

                      1. 36. ESI-FTICR Mass Spectrometry for Genomics and Proteomics Research: From Accurate Mass Determinations for Allele Subtyping to IRMPD for Phosphopeptide Mapping
                        David C. Muddiman
                        Pfizer Global, Ann Arbor, MI, 2001
                      2. 35. Nucleic Acid Analysis by High Performance Mass Spectrometry
                        David C. Muddiman
                        Washington-Baltimore Mass Spectrometry Discussion Group, Gaithersburg, MD, 2001
                      3. 34. Electrospray Ionization Fourier Transform Ion Cyclotron Resonance Mass Spectrometry of Macromolecules: Putting a Positive Spin on Negative Ions
                        David C. Muddiman
                        South Eastern Regional Meeting of the American Chemical Society, Savannah, GA, 2001
                      4. 33. Mass Spectrometric Approaches to Stratify Cancer Using Molecular Signatures
                        David C. Muddiman
                        Vanderbilt University, Nashville, TN, 2001
                      5. 32. Mass Spectrometry for the Study of Biocomplexity
                        David C. Muddiman
                        Virginia Commonwealth University Life Sciences Scholars’ Program, Richmond, VA, 2001
                      6. 31. Characterization of Macromolecules by Negative Electrospray Ionization Fourier Transform Ion Cyclotron Resonance Mass Spectrometry
                        David C. Muddiman
                        Eli Lilly, Indianapolis, IN, 2001
                      7. 30. Electrospray Ionization Fourier Transform Ion Cyclotron Resonance Mass Spectrometry for the Analysis of Large Biomolecules: Instrumentation and Applications
                        David C. Muddiman
                        Richmond Chromatography Discussion Group, Whitehall-Robbins, 2001
                      8. 29. Genotyping Short Tandem Repeat Polymorphisms by ESI FT-ICR Mass Spectrometry
                        David C. Muddiman
                        Joint Seminar: Departments of Pharmaceutics and Medicinal Chemistry, Medical College of Virginia, 2001
                      9. 28. Electrospray Ionization Fourier Transform Ion Cyclotron Resonance Mass Spectrometry with a DNA Twist
                        David C. Muddiman
                        3rd North American FT-ICR MS Conference, Austin, TX, 2001
                      10. 27. Genotyping Short Tandem Repeat Loci Using Accurate Mass Measurements and MS/MS by Electrospray Ionization FT-ICR Mass Spectrometry
                        David C. Muddiman
                        Clemson University, Clemson, South Carolina, 2001
                      11. 26. Genotyping Repetitive DNA Sequences with Non-consensus Alleles and Hypervariablity by Electrospray Ionization FT-ICR Mass Spectrometry
                        David C. Muddiman
                        Case Western Reserve University, Cleveland, Ohio, 2001
                      12. 25. Genomics to Proteomics: Bridging the Transcriptome with Electrospray Ionization FTICR Mass Spectrometry
                        David C. Muddiman
                        Pharmaceutical Congress of the Americas, American Association of Pharmaceutical Scientists, Orlando, FL, 2001

              2000Back to top

                      1. 24. Electrospray Ionization FT-ICR Mass Spectrometry of Large Biomolecules: Implications of Multiple-Charging for Exact and High Mass Measurements
                        David C. Muddiman
                        Workshop on Biological Fourier Transform Ion Cyclotron Resonance Mass Spectrometry, Providence, RI, November 6-7, 2000
                      2. 23. A Novel Algorithm for LC-MS: Enhancements in Both the Signal-to-Noise Ratio and the Resolution of the Analyte Peaks in the Chromatogram
                        David C. Muddiman
                        Chromfare, Richmond, VA, 2000
                      3. 22. Genotyping of Simple and Complex Short Tandem Repeats by Electrospray Ionization Tandem Mass Spectrometry
                        David C. Muddiman
                        Department of Biology, Virginia Commonwealth University, Richmond, VA, 2000

              1999Back to top

                      1. 21. Genomics to Gas-Phase Ion Chemistry: The Role of Mass Spectrometry in the Post-Genome Era
                        D.C. Muddiman
                        Department of Chemistry and the National High Magnetic Field Laboratory, Florida State University, Tallahassee, Florida, 1999
                      2. 20. Biological Mass Spectrometry: From Small Drugs to DNA
                        David C. Muddiman
                        Department of Chemistry, College of William and Mary, Williamsburg, VA, 1999
                      3. 19. Electrospray Ionization Fourier Transform Ion Cyclotron Resonance Mass Spectrometry: From Subattomoles to Gene Mapping
                        David C. Muddiman
                        Department of Chemistry, Kent State University, Kent, OH, 1999
                      4. 18. Electrospray Ionization Mass Spectrometry: A Powerful and Universal Platform for the Analysis of Genetic Variation
                        David C. Muddiman
                        Department of Chemistry, Louisiana State University, Baton Rouge, LA, 1999
                      5. 17. Investigations of Drug-DNA Interations and Antisense Therapeutics by Electrospray Ionization Fourier Transform Ion Cyclotron Resonance Mass Spectrometry
                        David C. Muddiman
                        Massey Cancer Center, Medical College of Virginia, Richmond, VA, 1999
                      6. 16. Electrospray Ionization FT-ICR Mass Spectrometry: A Powerful Platform for Genome and Proteome Characterization
                        David C. Muddiman
                        Atlanta Area Mass Spectrometry Discussion Group, Complex Carbohydrate Research Center, University of Georgia, Athens, GA, 1999
                      7. 15. Quantification of Relative Protein Ion Currents by Electrospray Ionization Fourier Transform Ion Cyclotron Resonance Mass Spectrometry
                        David C. Muddiman
                        Gordon Research Conference on Analytical Chemistry: Microbioanalytical Measurements for the Next Millennium, Henniker, New Hampshire, 1999
                      8. 14. Rapid and Accurate Characterization of STRs, VNTRs, and Drug-DNA Interactions Through the Development of ESI-FTICR Mass Spectrometry
                        David C. Muddiman
                        Functional Genomics: Technology Development and Research Applications, The Banbury Center, Cold Harbor Spring Laboratory, New York, 1999
                      9. 13. Biological Mass Spectrometry: Fundamentals and Applications in Biotechnology
                        David C. Muddiman
                        Hampton University, Hampton, VA, 1999

              1998Back to top

                      1. 12. Fourier Transform Ion Cyclotron Resonance Mass Spectrometry with a DNA Twist
                        David C. Muddiman
                        Eastern Analytical Symposium, Gold Medal Award Honoring Professor Alan Marshall, 1998
                      2. 11. Unraveling DNA using Electrospray Ionization Mass Spectrometry: A Powerful Platform for Genetic Mutation Screening
                        David C. Muddiman
                        Genome Sequencing and Analysis Conference, The Institute for Genomic Research, Miami Beach, Florida, 1998
                      3. 10. Electrospray Ionization Fourier Transform Mass Spectrometry for Genomic Research
                        David C. Muddiman
                        Merck and Co., West Point, PA, 1998
                      4. 9. High Performance Large Molecule Mass Spectrometry: Instrumentation and Genomics Applications
                        David C. Muddiman
                        Massey Cancer Center, Medical College of Virginia, 1998

              1997Back to top

                      1. 8. Combining New Analytical Developments with Genomics: A Multi-Disciplinary Approach with a World of Opportunity
                        David C. Muddiman
                        Department of Human Genetics, Medical College of Virginia, 1997

              1996Back to top

                      1. 7. Electrospray Ionization Mass Spectrometry of Oligonucleotides
                        David C. Muddiman
                        Department of Chemistry and Biochemistry, Montana State University, 1996

              1995Back to top

                      1. 6. Biological Applications of Mass Spectrometry: I) Investigation of Drugs, Metabolism and Pharmacokinetics II) Sequencing the Human Genome
                        David C. Muddiman
                        Odense University, Department of Molecular Biology, Odense, Denmark, 1995
                      2. 5. Investigation of Oligonucleotides by Electrospray Ionization Mass Spectrometry
                        David C. Muddiman
                        University of Münster, Institute for Medicinal Physics and Biophysics, Münster, Germany, 1995

              1994Back to top

                      1. 4. Application of Data Analysis Techniques to Time-of-Flight Mass Spectral Data to obtain Quantitative Information
                        David C. Muddiman, A.I. Gusev, A. Proctor, D.M. Hercules
                        Desorption ‘94, Bend, Oregon, 1994

              1993Back to top

                      1. 3. New Approaches Towards Measurement of Drugs and Metabolites in Microquantities by Time-of-Flight Mass Spectrometry
                        David C. Muddiman, A.I. Gusev, V. Warty, D.M. Hercules
                        Department of Clinical Chemistry, Children’s Hospital, Pittsburgh, PA, 1993
                      2. 2. Time-of-Flight Secondary Ion Mass Spectrometry: Instrumentation and Applications
                        David C. Muddiman, A.G. Sharkey, D.M. Hercules
                        Department of Geology, University of Pittsburgh, Pittsburgh, Pennsylvania, 1993

              1992Back to top

                  1. 1. Development of New Applications for Time-of-Flight Secondary-Ion Mass Spectrometry
                    David C. Muddiman, D.M. Hercules
                    Aluminum Corporation of America (ALCOA), Pittsburgh, Pennsylvania, 1992